These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3712080)

  • 1. Spurious thyroid cancer metastasis: saliva contamination artifact in high dose iodine-131 metastases survey.
    Park HM; Tarver RD; Schauwecker DS; Burt R
    J Nucl Med; 1986 May; 27(5):634-6. PubMed ID: 3712080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spurious metastasis on whole body scans in a patient with thyroid carcinoma.
    Bajramovic S; DeGroot LJ
    J Endocrinol Invest; 1998 Sep; 21(8):541-3. PubMed ID: 9801997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear imaging in the management of thyroid carcinoma.
    Cavalieri RR
    Thyroid; 1996 Oct; 6(5):485-92. PubMed ID: 8936676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-positive "necklace sign" on whole-body thyroid cancer survey--a case report.
    Beaulieu S; Djang D; Minoshima S
    J Nucl Med Technol; 2005 Mar; 33(1):42-3. PubMed ID: 15731020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contamination of a bracelet following iodine-131 therapy: a case report.
    Bybel B; Beebe W; Kim BY; Faiman C
    J Nucl Med Technol; 2000 Dec; 28(4):257-8. PubMed ID: 11142327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.
    Park HM; Perkins OW; Edmondson JW; Schnute RB; Manatunga A
    Thyroid; 1994; 4(1):49-54. PubMed ID: 8054861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake.
    Oyen WJ; Mudde AH; van den Broek WJ; Corstens FH
    J Nucl Med; 1995 Apr; 36(4):613-5. PubMed ID: 7699452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spurious thyroid cancer bone metastases on radioiodine scan due to external contamination.
    Bakheet SM; Hammami MM
    Eur J Radiol; 1993 Apr; 16(3):239-42. PubMed ID: 8508845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spurious lung metastases on radioiodine thyroid and whole body imaging.
    Bakheet S; Hammami MM
    Clin Nucl Med; 1993 Apr; 18(4):307-12. PubMed ID: 8482026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous metastasis from follicular carcinoma of the thyroid gland.
    Caron P; Moreau-Cabarrot A; Gorguet B; Bazex J
    Thyroid; 1993; 3(3):235-7. PubMed ID: 8257865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The radioactive handkerchief sign. A contamination artifact in I-131 imaging for metastatic thyroid carcinoma.
    Pochis WT; Krasnow AZ; Isitman AT; Cerletty JM; Kir KM; Hellman RS; Collier BD
    Clin Nucl Med; 1990 Jul; 15(7):491-4. PubMed ID: 2200627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of metastatic thyroid carcinoma after the administration of a therapeutic dose of 131-iodine.
    Preisman RA; Halpern S
    Eur J Nucl Med; 1978; 3(1):69-70. PubMed ID: 753625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the distribution of diagnostic and thyroablative I-131 in the evaluation of differentiated thyroid cancers.
    Nĕmec J; Röhling S; Zamrazil V; Pohunková D
    J Nucl Med; 1979 Feb; 20(2):92-7. PubMed ID: 430201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodine-131 treatment of thyroid cancer: absorbed dose calculated from post-therapy scans.
    Koral KF; Adler RS; Carey JE; Beierwaltes WH
    J Nucl Med; 1986 Jul; 27(7):1207-11. PubMed ID: 3723194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Scintigraphy using 131I in oxyphilic carcinomas of the thyroid gland].
    Hamann A; Gratz KF; Soudah B; Fritsch RS; Hundeshagen H
    Nuklearmedizin; 1994 Oct; 33(5):219-23. PubMed ID: 7997381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
    Lin JD; Kao PF; Chao TC
    Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical changes in iodine-131 scintigraphic findings in advanced follicular thyroid cancer.
    Krishna L; Dadparvar S; Brady LW; Micaily B; Meihofer M; Slizofski WJ; Brown SJ; Chevres A; Roman R; Khan AS
    J Nucl Med; 1993 Sep; 34(9):1574-6. PubMed ID: 8355078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.
    Sabra MM; Grewal RK; Tala H; Larson SM; Tuttle RM
    Thyroid; 2012 Sep; 22(9):877-83. PubMed ID: 22827641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodine-131 uptake in inflammatory lung disease: a potential pitfall in treatment of thyroid carcinoma.
    Höschl R; Choy DH; Gandevia B
    J Nucl Med; 1988 May; 29(5):701-6. PubMed ID: 3373306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.